The 78-year-old woman presented was coughing up blood along with a fever, sudden shortness of breath and was found to be in ...

Apellis (APLS) and Sobi announced the European Medicines Agency has validated an indication extension application for Aspaveli for the ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi ® (STO:SOBI) today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli ® (pegcetacoplan) ...

Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli® (pegcetacoplan) for the treatment of C3 ...

Employers and benefits advisors could use a new database to find places where kidney care or diabetes care costs a lot more ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

When Mike Shepherdson had a life-saving kidney transplant at the age of 13, the expectation was that, at best, it would work ...

Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.

HC Wainwright reiterated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report released on Thursday morning,Benzinga reports. HC Wainwright currently ...

Pune: Doctors at a private hospital in the city completed a marathon transplant of six organs — a liver, two lungs and three ...

Medically reviewed by Amelia MacIntyre, DO Scarlet fever, or scarlatina, is a bacterial infection that causes a distinctive ...

The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in ...